News and Updates

Two recent publications shed light on which people with type 1 diabetes will develop end-stage kidney disease, a complication of diabetes.

A recent update to continuous glucose monitor (CGM) coverage requirements will make it easier for people covered by Medicare to access CGM technology.

Breakthrough T1D is excited to announce that the T1D Fund portfolio company Protomer Technologies, who is developing "smart" insulin, has been acquired by Eli Lilly.

The FDA issued a letter to Provention Bio for the use of teplizumab to delay T1D in at-risk individuals, meaning that it has not been approved at this time.

There were a number of fantastic results at the ADA’s Scientific Sessions. Here is a video and a summary of the key takeaways from the conference.

Marilyn and Gerald Fishbone know first-hand how incredible research changes the lives of people with type 1 diabetes (T1D). For more than 50 years, they have been pillars in the T1D community dedicating their lives to helping advance innovative research. Marilyn remembers the day their 18-month-old son, Scott, was diagnosed. It was 1969. “I had […]

Here is Dr. Camillo Ricordi to share his key takeaways from day 4 from the American Diabetes Association's Scientific Sessions.

Here are Drs. Jennifer Sun, Dana Lewis, and Christine Wang to share their key takeaways from day 3, with their commentary in the video and below.

Drs. Danny Chou, Peter Arvan, Jeffrey Millman, and Efsun Arda will share their key takeaways from day 2, with their commentary in the video and below.

Here are Drs. Candace Reno and Luiza Caramori share their key takeaways from day 1, with their commentary in the video and below.